Eltrombopag Accord Healthcare

Eltrombopag Accord Healthcare is an oral medication used to stimulate platelet production. It is commonly prescribed for conditions affecting blood cell counts, such as certain types of anemia or low platelet levels.

Eltrombopag is primarily used to increase platelet counts in individuals with specific blood disorders. It works by stimulating the bone marrow to produce more platelets, which are essential for blood clotting. This medication is often prescribed for conditions where the body does not produce enough platelets on its own, such as in certain types of anemia or after chemotherapy.

Common effects of Eltrombopag may include headaches, nausea, and fatigue. Some individuals might experience dizziness or stomach discomfort. These effects vary and are not experienced by everyone who takes the medication.

Eltrombopag should be handled with care, especially for those with liver conditions or a history of blood clots. It is important to follow the advice of a healthcare provider regarding its use. Always inform your healthcare provider about any other medications you are taking.

Eltrombopag may interact with certain medications, including those that affect liver enzymes. It is advisable to avoid alcohol while taking this medication, as it can increase the risk of side effects. Always consult a healthcare provider before starting any new medication.